TrialCritical care (London, England)2023

Polymyxin B therapy based on therapeutic drug monitoring in carbapenem-resistant organisms sepsis: the PMB-CROS randomized clinical trial.

Shaohua Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.